Prepared for
MedTech
Hero Finding
The lead clinical feature carries roughly 3× the conjoint weight of upfront device cost: features drive this market, price is almost irrelevant.
Choice-based conjoint analysis across N=94 affluent healthcare consumers produced a clear hierarchy: the lead clinical feature was the dominant purchase driver, followed by contract-commitment terms, cardiologist reads per year, and a novel cardiac risk-scoring feature. Upfront device cost ranked last among the tested attributes. A vast majority of consumers chose the premium tier when offered alongside the standard option, and the incremental monthly cost for the premium tier was not a statistically meaningful barrier to premium adoption.
Vast majority
Chose premium tier when offered alongside standard option
Top driver
Lead clinical feature dominates relative importance
Near-universal
Rated cardiologist reading as extremely or very important
Study Design
N=94 affluent healthcare consumers · choice-based conjoint · 4 binary choice tasks + WTP elicitation + 30-minute qualitative depth.
The sample was designed to represent the target market: high-income individuals engaged with premium health services, stratified by cardiac health profile (preventative vs. active cardiac concern), concierge medicine usage, income tier, and age cohort.
Sample segmentation
Cardiac concern · 70
Preventative · 24
Interview guide · core topics
- Initial concept reaction: value proposition perception and competitive positioning vs. alternatives
- Choice task 1: standard tier — upfront vs. monthly pricing (options W and X)
- Choice task 2: premium tier vs. standard tier with annual commitment (Y vs. X)
- Choice task 3: premium tier vs. standard tier with device purchase (Z vs. W)
- Choice task 4: premium tier comparison — subscription vs. upfront + monthly (Y vs. Z)
- Cardiologist reading service: importance, preferred frequency, and willingness-to-pay by model
- AI-only model interest: willingness to substitute AI assessment for physician review
- Payment structure: upfront vs. monthly preferences and annual vs. month-to-month preferences
Recruit criteria
- High household income or net-worth threshold (top decile)
- Engaged with concierge medicine, executive health programs, or other premium healthcare services
- Adult primary target cohort, with younger and older cohorts included for cross-segment comparison
- Cardiac health interest: diagnosed condition, family history, symptoms, or preventative focus
Key Findings
What the conjoint data revealed about pricing architecture and feature priority.
Five signals shaped the company's pricing strategy, feature development roadmap, and go-to-market segmentation.
Vast majority
Chose premium tier (Option Y or Z) over standard options
Top driver
Lead clinical feature dominates conjoint relative importance
Near-universal
Rate cardiologist reading as extremely or very important
Strong majority
Prefer paying more for on-demand live cardiologist consultation
18 days
Kickoff to final report
01
Features dominate price by an order of magnitude in the conjoint model: the premium tier won on clinical capability, not on value-for-money.
The lead clinical feature, cardiologist access, and risk-factor scoring combined account for the large majority of the purchase decision weight. Upfront device cost ranks last among tested attributes; commitment structure ranks ahead of price but well behind the clinical features. The practical implication: a consumer who is choosing between standard and premium is choosing on clinical capability and peace of mind, not on total cost of ownership. Price objections in this segment are almost entirely resolved by feature differentiation, not by discounting.
02
A vast majority chose the premium tier across all demographic segments: the premium is the market, not a niche segment.
Premium tier preference held above 90% across preventative-health users, cardiac-concern users, concierge-medicine users, and non-concierge users. The only demographic with meaningful standard-tier representation was the older age cohort. The market is not divided between premium buyers and standard buyers: it is a premium-first market where the standard tier serves edge-case use.
03
Cardiologist reading service is non-negotiable: a near-universal majority rate it extremely or very important, and AI-only models show meaningful but minority interest.
The physician relationship is the core value proposition, not the hardware. A near-universal majority rate cardiologist reading as extremely or very important; a majority of those rate it extremely important. Interest in AI-only assessment is meaningful (about half of respondents indicate very or extremely interested) but does not replace the physician option, and a non-trivial minority is not at all interested in AI-only. The practical recommendation: AI analysis is an additive feature, not an alternative service. Positioning it as 'AI plus physician' is both accurate and maximally appealing.
04
Concierge-medicine users are the highest-value segment: their willingness to pay across every pricing metric is multiples of non-concierge users.
Concierge-medicine users (a small majority of the sample) demonstrate WTP that is several times higher than non-users on monthly subscription, annual subscription, and per-reading metrics. The largest gap is in pay-per-reading WTP. Concierge users also place almost no importance on payment-structure factors in the conjoint: for this cohort, the decision is purely about clinical capability and professional access, not subscription mechanics.
05
The no-commitment premium configuration is the overall preferred option: flexibility is the decisive differentiator between the two premium tiers.
Between the two premium options, the no-annual-commitment configuration won the overall sample. The deciding factor is not price; the annual-commitment requirement in the alternative configuration is negatively weighted in the conjoint model. Consumers who prefer the annual-commitment configuration are younger and skew toward concierge-medicine users. The implication: offering both premium configurations captures both cohorts.
“There is absolutely no way I would want someone other than a cardiologist reviewing my ECG data. There are too many different rhythms in the PQRST complex. It needs to be a board-certified cardiologist. Not AI, not a nurse. A cardiologist.”— High-income consumer, non-concierge, cardiac concerns
Crosstab · WTP by Segment
Concierge-medicine users are willing to pay multiples more per cardiologist reading than non-users: premium willingness is anchored to existing premium health spending behavior.
Willingness-to-pay benchmarks and feature preferences by concierge-medicine usage. Values reindexed within row to peak segment = 100. Highlighted row shows the most dramatic WTP differential in the dataset.
| Concierge Users (n=51) | Non-Concierge Users (n=43) | |
|---|---|---|
| WTP per cardiologist reading (indexed) | 100 | 26 |
| WTP monthly subscription (indexed) | 100 | 41 |
| WTP annual subscription (indexed) | 100 | 60 |
| Prefer premium tier | 100 | 96 |
| Pay more for live consultation | 100 | 73 |
| Pay more for novel feature access | 100 | 70 |
N=94 · all participants expressed positive interest in the product conceptConcierge WTP per reading is multiples of non-conciergeIndexed · blinded values
Voice of Customer
How affluent healthcare consumers describe what they are actually buying.
Verbatims from AI-moderated interviews across health profiles and income tiers, selected to represent the range of views on cardiologist value, AI substitution, and premium tier rationale.
Premium Tier Value · Cardiologist Essential
“A cardiologist has specialized training and expertise to accurately interpret ECG data. We decrease the risks of misdiagnosis or misinterpretation. Having AI is helpful, but a cardiologist can spot subtle issues and provide personalized advice that no algorithm replaces. That professional expertise is what I am paying for.”
— Preventative health consumer, concierge-medicine user
No-Commitment Logic
“I would prefer the no-commitment option because of the live consultation with the cardiologist and the early access to novel cardiac risk scores. The flexibility is also critical. I want to be able to stop if the service does not deliver on what it promises.”
— Cardiac concern consumer, concierge-medicine user
Annual-Commitment Logic
“The annual-commitment option offers significantly more value for the additional cost, especially if you have any concern about your cardiac health. The live consultation option and the advanced risk assessment make it a more comprehensive and potentially life-saving option.”
— High-income consumer, cardiac concern, concierge user
AI Substitution · Resistant
“I think I would trust a human more than AI. I am not saying AI is bad. I am saying I prefer a human to review it for me. I want to see the emotion, the person's face, the one-on-one engagement with a human. That is what peace of mind actually means.”
— Preventative health consumer, non-concierge
Multi-Tier Pricing · Skeptical
“Too many options make the product seem cheap. Offer a bare-bones version so people will value the higher-end plan. If everything looks like a variation on the same product, people wonder what they are really getting for the premium.”
— Cardiac concern consumer, concierge-medicine user
Counter-intuitive
Preventative health users (no cardiac diagnosis) are the highest-value customers, not the cardiac-concern segment.
The prevailing assumption before the study was that consumers with diagnosed cardiac conditions, family history, or symptoms would be the premium buyers: they have the most to gain from clinical-grade monitoring. The conjoint data reversed that assumption. Preventative-health users chose premium options at the highest rate in the sample (essentially universal), rated cardiologist reading higher on importance than the cardiac-concern cohort, required monthly cardiologist readings at a meaningfully higher rate, and had the highest absolute willingness to pay. The preventative user is not the cautious, price-sensitive buyer: they are the aspirational, anxiety-motivated buyer who sees clinical-grade monitoring as a status signal and a proactive investment, not a reactive medical tool.
Strategic Implications
Three pricing and commercial moves from the research.
What the executive team took into launch pricing architecture and go-to-market segmentation, grounded in the conjoint output and WTP data.
01
Launch with both premium configurations as the offer set, not a single premium SKU.
The no-commitment configuration wins overall, but the annual-commitment configuration wins among younger consumers and concierge-medicine users. A single-premium launch forfeits one of those cohorts. Both options carry essentially the same feature set with different payment structures; offering both is not complexity for its own sake — it is matching payment structure to the cohort's dominant preference. The standard tier should remain available but not merchandised equally: it is a fallback, not a lead offer.
02
Target concierge-medicine users as the primary acquisition channel: their WTP is multiples of non-users and their interest in premium features is near-universal.
Concierge-medicine users already spend at a level where a cardiac-monitoring subscription is a natural adjacency. Partnership with concierge-medicine practices, executive health programs, and high-end primary care networks creates an acquisition path that pre-selects for the highest-WTP segment without requiring any premium price justification: these consumers have already demonstrated the spending behavior.
03
Position the lead clinical feature as the primary hero feature and price anchor.
The lead clinical feature dominates feature importance in the conjoint model but is delivered as a bundle within the premium tier. In all external marketing, the lead clinical feature should be the lead claim and the primary response to value-justification questions. The conjoint part-worth utilities confirm that a product including this feature carries the single largest feature delta in the model. The pricing architecture is sound; the marketing should be built around the product's single most powerful feature.
Success criteria · 12 months
- Premium tier represents the strong majority of subscriptions at 90 days post-launch
- Concierge-medicine channel partnership agreements in place before launch
- Lead clinical feature featured prominently in all top-of-funnel creative and copy
Risk register
| Regulatory clearance delay on lead clinical feature | HIGH |
| AI-only competitor undercutting on price | MED |
| Multi-tier pricing complexity reducing conversion | MED |
| Skewed sample limiting cross-segment generalization | LOW |